Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fibrocell Science, Inc. (ILE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fibrocell Science, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 357097.
Total stock buying since 2014: $9,224,040.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 3,000 | $6,185 | 0 | $0 | 0 | $0 |
| 2017 | 2,727,273 | $2,100,000 | 0 | $0 | 0 | $0 |
| 2016 | 50,000 | $46,100 | 0 | $0 | 0 | $0 |
| 2015 | 1,002,087 | $5,788,880 | 0 | $0 | 0 | $0 |
| 2014 | 443,057 | $1,282,875 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-08 | 3,000 | $6,185 | 0 | $0 | 0 | $0 |
| 2017-12 | 2,727,273 | $2,100,000 | 0 | $0 | 0 | $0 |
| 2016-12 | 50,000 | $46,100 | 0 | $0 | 0 | $0 |
| 2015-11 | 3,000 | $14,996 | 0 | $0 | 0 | $0 |
| 2015-08 | 6,500 | $41,880 | 0 | $0 | 0 | $0 |
| 2015-07 | 975,987 | $5,660,724 | 0 | $0 | 0 | $0 |
| 2015-05 | 16,600 | $71,280 | 0 | $0 | 0 | $0 |
| 2014-12 | 5,000 | $12,600 | 0 | $0 | 0 | $0 |
| 2014-11 | 6,000 | $15,225 | 0 | $0 | 0 | $0 |
| 2014-06 | 432,057 | $1,255,050 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-22 | Maslowski John Michael (CEO) | Buy | 3,000 | 2.06 | 6,185 |
| 2017-12-11 | Intrexon Corp | Buy | 2,727,273 | .77 | 2,100,000 |
| 2016-12-02 | Pernock David (Chairman and CEO) | Buy | 50,000 | .92 | 46,100 |
| 2015-11-13 | Pernock David (Chairman and CEO) | Buy | 3,000 | 5.00 | 14,996 |
| 2015-08-11 | Maslowski John Michael (VP, Scientific Affairs) | Buy | 1,000 | 6.33 | 6,330 |
| 2015-08-11 | Goldan Keith A. (SVP and CFO) | Buy | 2,000 | 6.33 | 12,660 |
| 2015-08-11 | Pernock David (Chairman and CEO) | Buy | 3,500 | 6.54 | 22,890 |
| 2015-07-27 | Intrexon Corp | Buy | 975,987 | 5.80 | 5,660,724 |
| 2015-05-13 | Pernock David (Chairman and CEO) | Buy | 16,600 | 4.29 | 71,280 |
| 2014-12-12 | Pernock David (Chairman and CEO) | Buy | 5,000 | 2.52 | 12,600 |
| 2014-11-20 | Maslowski John Michael (VP, Scientific Affairs) | Buy | 1,000 | 2.54 | 2,540 |
| 2014-11-20 | Pernock David (Chairman and CEO) | Buy | 5,000 | 2.54 | 12,685 |
| 2014-06-05 | St.clare Christine (Director) | Buy | 10,000 | 3.00 | 30,000 |
| 2014-06-05 | Pernock David (Chief Executive Officer) | Buy | 12,500 | 2.95 | 36,925 |
| 2014-06-04 | Moore Kelvin (Director) | Buy | 4,557 | 2.99 | 13,625 |
| 2014-06-04 | Mazur Marc (Director) | Buy | 5,000 | 2.90 | 14,500 |
| 2014-06-04 | Intrexon Corp | Buy | 400,000 | 2.90 | 1,160,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ILE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fibrocell Science, Inc. (symbol ILE, CIK number 357097) see the Securities and Exchange Commission (SEC) website.